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Introduction: Selective laser trabeculoplasty is a treatment option to lower intraocular pressure in patients with
glaucoma. It has been proven to work in adults. We describe two pediatric patients with glaucoma who responded
well to selective laser trabeculoplasty.
Case presentations: Two patients with pediatric glaucoma underwent selective laser trabeculoplasty. Patient 1 was
a nine-year-old Iranian Asian girl with secondary aphakic glaucoma who was taking four glaucoma medications.
She had a 50% decrease in intraocular pressure five weeks after selective laser trabeculoplasty. She was able to
discontinue all four glaucoma drops after treatment. Patient 2 was a 13-year-old Filipino Caucasian boy who
presented with early juvenile open-angle glaucoma and who was on no medications. He had a 40% drop in
intraocular pressure four weeks after selective laser trabeculoplasty.
Conclusion: Selective laser trabeculoplasty can decrease intraocular pressure in pediatric patients with glaucoma,
both as a primary and secondary therapy. This study demonstrates that selective laser trabeculoplasty is a good
option for the treatment of glaucoma in the pediatric population.Introduction
Selective laser trabeculoplasty (SLT) was developed in
1999 to reduce intraocular pressure (IOP) in patients
with glaucoma [1]. Because SLT selectively targets the
pigmented trabecular meshwork cells, it is a more gentle
treatment than argon laser trabeculoplasty. There is no
histologic scarring or coagulative damage to the trabecular
meshwork [2], thus reducing collateral damage to sur-
rounding tissues. The incidence of iritis and elevated IOP
is much lower compared with argon laser trabeculoplasty
[3]. In adults, SLT has a variable success rate (40% to 70%)
[4-6] but has been shown to be safe [6]. SLT is also safe as
initial therapy in both open-angle glaucoma and patients
with ocular hypertension [7,8].
The incidence of congenital cataracts is 1.2 to 6 cases
per 10,000. Congenital glaucoma is rare. Primary conge-
nital glaucoma is rare, occurring in one in 10,000 births.
Secondary congenital glaucoma can follow cataract extrac-
tion in infants. Congenital glaucoma is usually treated sur-
gically, not medically. Laser trabeculoplasty is typically not
successful in aphakic or congenital glaucoma [9].* Correspondence: jsongmd@drsongvision.com
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Patient 1
The patient was a nine-year-old Iranian Asian girl with
aphakic congenital glaucoma OS. Her past medical his-
tory was non-contributory. Her past ocular history was
significant for congenital cataracts; she was s/p cataract
extraction in infancy in both eyes. Her family history
was significant for a younger brother with congenital
cataracts who also underwent cataract extraction in both
eyes but did not develop glaucoma.
Our patient had been referred for elevated IOP in her
left eye. Her visual acuity was 20/20 in each eye. Preopera-
tively, her average IOPs were 15mmHg in her right eye
and 23mmHg in her left eye, recorded by the same exa-
miner. She was on four topical glaucoma medications for
her left eye: timolol-brimonidine (Combigan®, Allergan,
Irvine, CA, USA) three times a day, brinzolamide (Azopt®,
Alcon, Fort Worth, TX, USA) three times a day and
bimatoprost (Lumigan®, Allergan) every bedtime. Slit lamp
examination revealed aphakia in both eyes. Gonioscopy
revealed open anterior chamber angles to grade IV with
rare pigment in both eyes and rare peripheral anterior
synechiae in her left eye. Dilated fundus examination
showed optic nerve cupping of 0.2 in both eyes, withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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nesses were 546μm and 588μm. Visual field testing
showed a full visual field in her right eye and an early in-
ferior arcuate defect in her left eye. Heidelberg retinal
tomography showed a full nerve fiber layer in her right
eye but a very thin nerve fiber layer in her left eye.
After informed consent was obtained from her mother,
our patient underwent SLT in her left eye with settings
of: 0.5mJ to 0.9mJ, 80 spots, 360°, 0.3 nanoseconds. She
tolerated the procedure well without side effects.
By postoperative week 5, our patient had a 50% drop
in her IOP from 23mmHg to 9mmHg. Over the next
few months, she was able to discontinue all four of her
topical glaucoma medications. Her response to SLT was
sustained for 10 months. She subsequently underwent a
second SLT treatment in her left eye with a modest IOP
drop. Her IOP remained stable six months after the
second SLT treatment (14 months after the first SLT
treatment), and the visual field defect in her left eye im-
proved and normalized one year later. Eight months
after the second SLT treatment in her left eye, her IOPs
were stable at 18mmHg in both eyes.
Patient 2
The second patient was a 13-year-old Filipino Caucasian
boy with open-angle glaucoma (more in his right eye
than left). His past medical history was noncontributory.
His past ocular history was negative for trauma or sur-
gery. His family history was negative for glaucoma.
His visual acuity was 20/20 in each eye. Preoperatively,
his IOPs were on average 23mmHg in his right eye and
19mmHg in his left eye, recorded by the same examiner.
He was on no glaucoma medications. Slit lamp examin-
ation revealed deep and quiet anterior chambers and
clear lenses in both eyes. Gonioscopy revealed open
anterior chamber angles to grade IV OU with rare pig-
ment. A dilated fundus examination revealed optic nerve
cupping of 0.9 in both eyes, with normal vessels, maculae
and periphery. Ancillary testing revealed normal corneal
thicknesses of 562μm and 555μm. Visual field testing
revealed a superonasal step and an enlarged blind spot in
his right eye and full visual field in his left eye. Heidelberg
retinal tomography revealed very thin nerve layers super-
otemporally and inferotemporally in his right eye and a
very thin nerve layer superotemporally in his left eye.
Our patient did not want to start topical glaucoma
medications. After informed consent was obtained from
his mother, our patient underwent selective SLT in his
right eye with settings of: 0.8mJ, 100 spots, 360°, 0.3
nanoseconds. He tolerated the procedure well without
side effects.
By postoperative week 4, our patient had a 39% drop
in his IOP from 23mmHg to 14mmHg. His IOPs were
17mmHg and 21mmHg, respectively at four months; bysix months, the IOP was 19mmHg in both eyes (still
lower than the baseline of 23mmHg in his right eye).
Discussion
These are the first reported two cases of SLT success in
pediatric patients with glaucoma (one with secondary
aphakic glaucoma and one with juvenile open-angle
glaucoma). Both patients had significant reductions in
IOP after SLT (50% and 39%). Our first patient was able
to discontinue all four topical medications. Our second
patient did not need to use topical glaucoma medication.
This study demonstrates that SLT may be a viable
treatment option prior to incisional glaucoma treatment
or glaucoma medications. It also demonstrates that SLT
is efficacious as an adjunct or as primary therapy [10].
As in adults, SLT in the pediatric population can be used
to help patients discontinue glaucoma medications [11].
Also as in adults, the efficacy of SLT diminishes over
time [12,13]. Our first patient's scenario demonstrated
that SLT can be safely repeated, as demonstrated in
other studies [14]. Both patients had IOP lowering in
their contralateral eyes as well, as demonstrated in prior
studies [15]. The limitations of this study include its
retrospective nature as well as the small sample size.
Our second patient needs longer follow-up. Larger stud-
ies should be done to confirm these encouraging results.
Conclusions
SLT is a safe and efficacious treatment for pediatric pa-
tients with glaucoma, both as primary and adjunct therapy.
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